Blinklab Limited (AU:BB1) has released an update.
BlinkLab Limited has embarked on a strategic partnership with Turning Pointe Autism Foundation to enhance autism diagnosis using AI-powered tools through a clinical study involving 200 children. The collaboration, which will refine BlinkLab’s AI algorithms in preparation for an FDA registration study, underscores the company’s commitment to making neurobehavioral testing more accessible and efficient via smartphone technology. This initiative represents a significant advancement in the field of autism research and the accessibility of diagnostic care.
For further insights into AU:BB1 stock, check out TipRanks’ Stock Analysis page.
